Bionovate Technologies Overview
Valuation check: BIIO's ROE is 20.06%, above the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow20.06%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Bionovate Technologies (BIIO) currently reports a ROE of 20.06%. That is above the sector sector average of 11.64%. Use the charts on this page to explore Bionovate Technologies's ROE history and peer comparisons.
Bionovate Technologies's ROE of 20.06% is higher than the its sector sector average of 11.64%. That is roughly 72.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Bionovate Technologies's current 20.06% should be judged against industry norms (sector average: 11.64%) and against BIIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 20.06%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for Bionovate Technologies, and consider following BIIO for alerts when major investors trade the stock.
